ED
Global Health EDCTP3 Joint Undertaking (EDCTP3)

Global Collaboration Action for Prevention and Treatment of Lower Respiratory Tract Infections (LRTIs) in Sub-Saharan Africa

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

ClosedGlobal Health EDCTP3 Joint Undertaking (EDCTP3)EUAlbaniaArmeniaBosnia and HerzegovinaCanadaFaroe IslandsGeorgiaIcelandIsraelKosovoMoldovaMontenegroNew ZealandNorth MacedoniaNorwaySerbiaSouth KoreaSwitzerlandTunisiaTรผrkiyeUkraineUnited KingdomEgyptMoroccoBJBFBICMCICDEthiopiaSZGAGMGhanaGWGNKenyaLRMWMLMZNENigeriaCGRwandaSenegalSLSOSouth AfricaTanzaniaUgandaZMZW

Unlike most Horizon Europe topics, the scoring rubric for the second stage is spelled out here rather than deferred to a general annex: each of the three criteria โ€” Excellence, Impact, and Quality and Efficiency of Implementation โ€” is scored out of 5, with individual thresholds of 4, 4 and 3 respectively, plus an overall threshold of 12 across the three combined. Among proposals that clear those tโ€ฆ

This topic wants late-stage (Phase IIb onward) clinical studies evaluating prevention or treatment measures against a specific list of LRTI pathogens โ€” including S. pneumoniae, RSV, influenza and several others โ€” in sub-Saharan Africa, with priority on interventions close to availability such as Phase III assets or products already approved in the EU/US. Tuberculosis, CMV, human coronaviruses and fungi are explicitly out of scope, as are antibiotics; prophylactic vaccines, monoclonal antibodies and other antivirals are the intended interventions.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.โ‚ฌ33.9M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
European Commission logo
Scheduled

Prevention and management of chronic non-communicable diseases in children and young people

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds implementation research that helps children and young people prevent and manage chronic disease equitably.

MedtechBiotech
โ‚ฌ3M โ€“ โ‚ฌ4MApr'27
European Commission logo
Scheduled

Cancer Mission: Functional Genomics for New Treatments

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ7โ€“8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.

BiotechMedtech+2
โ‚ฌ7M โ€“ โ‚ฌ8MSep'27
AU
Open

Osteoarthritis Treatments Research Consortium

๐Ÿ‡ฌ๐Ÿ‡งArthritis UK ยท United Kingdom

Funds a UK osteoarthritis drug-development consortium, up to ยฃ3 million over 5 years.

MedtechBiotech
ยฃ3MSep'26
Cancer Research UK logo
Open

Prevention and Population Programme Award

๐Ÿ‡ฌ๐Ÿ‡งCRUK ยท United Kingdom

Funds UK cancer researchers up to ยฃ2.5m over five years for prevention and population studies.

BiotechMedtech
ยฃ2.5MSep'26
European Commission logo
Scheduled

Independent Living and Inclusion for Persons with Disabilities

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.

MedtechBiotech
โ‚ฌ6M โ€“ โ‚ฌ8MApr'27
European Commission logo
Scheduled

Innovative healthcare interventions for non-communicable diseases

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ7โ€“8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.

BiotechMedtech
โ‚ฌ7M โ€“ โ‚ฌ8MApr'27